Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial

Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide notice about NIH terminology during a transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T15:37:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:00:44.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:07:19.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and blocking access to the study details. This is an access issue rather than an update to core page content such as the study description or eligibility criteria.
    Difference
    19%
    Check dated 2026-09-20T22:27:38.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study's conditions section no longer lists Cystic Fibrosis, and the related topics/MedlinePlus Genetics references have been removed, altering the contextual information and available educational links for readers.
    Difference
    0.2%
    Check dated 2026-09-13T18:59:22.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now includes 'Cystic fibrosis' as a related topic and adds MedlinePlus Genetics to the related topics. This expands the background resources available for users reviewing the study record.
    Difference
    0.2%
    Check dated 2026-09-06T17:21:20.000Z thumbnail image

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.